XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.3
SCHEDULE OF REVISION ON THE PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable $ 9,244,321             $ 9,244,321   $ 10,854,084 $ 6,265,762
Other current assets 4,252,613             4,252,613   3,672,231  
Total Current Assets 41,085,605             41,085,605   52,369,360  
Total Assets 65,983,378             65,983,378   76,096,297  
Accrued expenses 22,079,805             22,079,805   22,811,763  
Deferred revenue 14,355,531 $ 16,902,735   $ 20,585,735 $ 18,437,744   $ 16,902,735 14,355,531 $ 20,585,735 19,625,940 9,711,305
Total Current Liabilities 56,663,553             56,663,553   67,400,168  
Total Liabilities 62,615,226             62,615,226   83,650,417  
Accumulated deficit 247,790,178             247,790,178   239,850,931  
Total LifeMD, Inc. Stockholders’ Deficit (1,314,334)             (1,314,334)   9,083,214  
Non-controlling interest (2,053,818)             (2,053,818)   (1,529,094)  
Total Stockholders’ Deficit (3,368,152) 4,239,744 $ 5,470,088 5,097,347 1,891,625 $ (2,392,950) 4,239,744 (3,368,152) 5,097,347 7,554,120 (4,189,049)
Total Liabilities, Mezzanine Equity and Stockholder’s Deficit 65,983,378             65,983,378   76,096,297  
Total revenues, net 60,172,470 62,673,395 64,129,174 53,272,294     126,802,569 186,975,039 149,337,063 208,839,282  
Gross profit 52,764,557 55,242,491 55,485,458 48,258,753     110,727,949 163,492,506 134,698,430 184,770,803  
General and administrative expenses 16,589,390     18,115,143       51,210,246 51,160,883 71,179,108  
Total expenses 54,733,771     52,255,027       164,938,940 149,131,478 203,047,127  
Operating income (loss) (1,969,214) (451,562) 974,342 (3,996,274)     522,780 (1,446,434) (14,433,048) (18,276,324)  
Loss from operations before income taxes 3,387,521     4,554,871       4,154,043 16,000,791 (20,458,141)  
Net income (loss) (3,556,655) (1,114,589) 348,067 (4,787,394) (7,534,958) (3,910,962) (766,522) (4,323,177) (16,233,314) (20,860,141)  
Net (loss) income attributable to noncontrolling interests 249,462     (129,472)       1,286,382 237,037 548,875  
Net loss attributable to LifeMD, Inc. (3,806,117) (1,619,664) (183,778) (4,657,922)     (1,803,442) (5,609,559) (16,470,351) (21,409,016)  
Net loss attributable to LifeMD, Inc. common stockholders (4,582,680) $ (2,396,226) $ (960,341) $ (5,434,485)     $ (3,356,567) (7,939,247) $ (18,800,039) $ (24,515,266)  
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ (0.05) $ (0.02) $ (0.13)     $ (0.08)   $ (0.46) $ (0.60)  
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ (0.05) $ (0.02) $ (0.13)     $ (0.08)   $ (0.46) $ (0.60)  
Non-controlling interest (3,368,152) $ 4,239,744 $ 5,470,088 $ 5,097,347 1,891,625 (2,392,950) $ 4,239,744 (3,368,152) $ 5,097,347 $ 7,554,120  
Accounts receivable     (467,855)       1,533,367 1,609,763 (5,222,534) (4,588,323)  
Other current assets               (580,382) (2,303,495) (2,737,721)  
Deferred revenue     206,460       (2,723,205) (5,270,408) 10,874,430 9,914,635  
Accrued expenses             (5,365,264) (731,959) 7,607,005 8,019,711  
Net cash provided by operating activities     3,068,387       11,707,834 11,560,698 16,439,889 17,513,190  
Loss from operations before income taxes (3,387,521)     (4,554,871)       (4,154,043) (16,000,791) 20,458,141  
Distributions to non-controlling interest               (761,658) (603,048)    
Net cash used in financing activities               (12,618,450) (3,183,770)    
Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit 247,790,178 243,207,498 240,811,272 234,135,704 228,701,219 220,247,978 243,207,498 247,790,178 234,135,704 239,850,931 215,335,665
Net income (loss) (3,806,117) (1,619,664) (183,778) (4,657,922) (7,676,679) (4,135,750)          
Non-controlling interest 247,790,178 243,207,498 240,811,272 234,135,704 228,701,219 220,247,978 243,207,498 247,790,178 234,135,704 239,850,931  
Noncontrolling Interest [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit (2,053,818) (2,253,895) (2,024,939) (1,388,096) (1,553,568) (1,676,078) (2,253,895) (2,053,818) (1,388,096) (1,529,094) $ (1,754,107)
Net income (loss) 249,462 505,075 531,845 (129,472) 141,721 224,788          
Non-controlling interest (2,053,818) (2,253,895) (2,024,939) (1,388,096) $ (1,553,568) $ (1,676,078) (2,253,895) (2,053,818) (1,388,096) (1,529,094)  
Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total revenues, net $ 47,279,933 49,018,882 50,887,899 40,154,683     99,906,781 $ 147,186,714 109,687,054 154,824,075  
Previously Reported [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable                   8,217,813  
Other current assets                   2,672,231  
Total Current Assets                   48,733,089  
Total Assets                   72,460,026  
Accrued expenses                   20,811,763  
Deferred revenue                   14,480,917  
Total Current Liabilities                   60,255,145  
Total Liabilities                   76,505,394  
Accumulated deficit                   236,253,218  
Total LifeMD, Inc. Stockholders’ Deficit                   5,485,501  
Non-controlling interest                   (1,440,133)  
Total Stockholders’ Deficit                   4,045,368  
Total Liabilities, Mezzanine Equity and Stockholder’s Deficit                   72,460,026  
Total revenues, net   62,218,185 65,697,756 53,393,157     127,915,941   148,199,266 212,453,838  
Gross profit   54,787,281 57,054,040 48,379,616     111,841,321   133,560,633 188,385,359  
General and administrative expenses       18,925,844         52,752,961 72,662,021  
Total expenses       53,065,728         150,723,556 204,530,040  
Operating income (loss)   (906,772) 2,542,924 (4,686,112)     1,636,152   (17,162,923) (16,144,681)  
Loss from operations before income taxes       5,244,709         18,730,666 (18,326,498)  
Net income (loss)   (1,569,799) 1,916,649 (5,477,232)     346,850   (18,963,189) (18,728,498)  
Net (loss) income attributable to noncontrolling interests       (345,767)         (187,729) 153,234  
Net loss attributable to LifeMD, Inc.   (2,074,874) 1,384,804 (5,131,465)     (690,070)   (18,775,460) (18,881,732)  
Net loss attributable to LifeMD, Inc. common stockholders   $ (2,851,436) $ 608,241 $ (5,908,028)     $ (2,243,195)   $ (21,105,148) $ (21,987,982)  
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ (0.06) $ 0.01 $ (0.14)     $ (0.05)   $ (0.52) $ (0.53)  
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ (0.06) $ 0.01 $ (0.14)     $ (0.05)   $ (0.52) $ (0.53)  
Non-controlling interest                   $ 4,045,368  
Accounts receivable     $ (1,974,961)       $ 887,684   $ (722,251) (2,940,563)  
Other current assets                 (1,303,495) (1,737,721)  
Deferred revenue     144,985       (2,690,893)   7,561,943 5,652,319  
Accrued expenses             (5,865,264)   7,704,036 7,502,624  
Net cash provided by operating activities     3,068,387       11,707,834   15,944,841 17,513,190  
Loss from operations before income taxes       $ (5,244,709)         (18,730,666) 18,326,498  
Distributions to non-controlling interest                 (108,000)    
Net cash used in financing activities                 (2,688,722)    
Previously Reported [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit   $ 238,496,413 235,644,977 235,370,384     238,496,413   235,370,384 236,253,218  
Non-controlling interest   238,496,413 235,644,977 235,370,384     238,496,413   235,370,384 236,253,218  
Previously Reported [Member] | Noncontrolling Interest [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit   (2,164,934) (1,935,978) (1,765,058)     (2,164,934)   (1,765,058) (1,440,133)  
Non-controlling interest   (2,164,934) (1,935,978) (1,765,058)     (2,164,934)   (1,765,058) (1,440,133)  
Previously Reported [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total revenues, net   48,563,672 52,456,481 40,275,546     101,020,153   108,549,257 158,438,631  
Revision of Prior Period, Reclassification, Adjustment [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable                   2,636,271  
Other current assets                   1,000,000  
Total Current Assets                   3,636,271  
Total Assets                   3,636,271  
Accrued expenses                   2,000,000  
Deferred revenue                   5,145,023  
Total Current Liabilities                   7,145,023  
Total Liabilities                   7,145,023  
Accumulated deficit                   3,597,713  
Total LifeMD, Inc. Stockholders’ Deficit                   3,597,713  
Non-controlling interest                   (88,961)  
Total Stockholders’ Deficit                   3,508,752  
Total Liabilities, Mezzanine Equity and Stockholder’s Deficit                   3,636,271  
Total revenues, net   455,210 (1,568,582) (120,863)     (1,113,372)   1,137,797 (3,614,556)  
Gross profit   455,210 (1,568,582) (120,863)     (1,113,372)   1,137,797 (3,614,556)  
General and administrative expenses       (810,701)         (1,592,078) (1,482,913)  
Total expenses       (810,701)         (1,592,078) (1,482,913)  
Operating income (loss)   455,210 (1,568,582) 689,838     (1,113,372)   2,729,875 (2,131,643)  
Loss from operations before income taxes       (689,838)         (2,729,875) (2,131,643)  
Net income (loss)   455,210 (1,568,582) 689,838     (1,113,372)   2,729,875 (2,131,643)  
Net (loss) income attributable to noncontrolling interests       216,295         424,766 395,641  
Net loss attributable to LifeMD, Inc.   455,210 (1,568,582) 473,543     (1,113,372)   2,305,109 (2,527,284)  
Net loss attributable to LifeMD, Inc. common stockholders   $ 455,210 $ (1,568,582) $ 473,543     $ (1,113,372)   $ 2,305,109 $ (2,527,284)  
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ 0.01 $ (0.03) $ 0.01     $ (0.03)   $ 0.06 $ (0.07)  
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ 0.01 $ (0.03) $ 0.01     $ (0.03)   $ 0.06 $ (0.07)  
Non-controlling interest                   $ 3,508,752  
Accounts receivable     $ 1,507,106       $ 645,683   $ (4,450,283) (1,647,760)  
Other current assets                 (1,000,000) (1,000,000)  
Deferred revenue     61,475       (32,312)   3,312,487 4,262,316  
Accrued expenses             500,000   (97,031) 517,087  
Net cash provided by operating activities             495,048  
Loss from operations before income taxes       $ 689,838         2,729,875 2,131,643  
Distributions to non-controlling interest                 (495,048)    
Net cash used in financing activities                 (495,048)    
Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit   $ 4,711,085 5,166,295 (1,234,680)     4,711,085   (1,234,680) 3,597,713  
Non-controlling interest   4,711,085 5,166,295 (1,234,680)     4,711,085   (1,234,680) 3,597,713  
Revision of Prior Period, Reclassification, Adjustment [Member] | Noncontrolling Interest [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Deficit   (88,961) (88,961) 376,962     (88,961)   376,962 (88,961)  
Non-controlling interest   (88,961) (88,961) 376,962     (88,961)   376,962 (88,961)  
Revision of Prior Period, Reclassification, Adjustment [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total revenues, net   $ 455,210 $ (1,568,582) $ (120,863)     $ (1,113,372)   $ 1,137,797 $ (3,614,556)